| FRESENIUS SE+CO.KGAA O.N. | 49.420 / -0.85% |
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/11/2019 / 23:35 - GlobeNewswire - eGenesis Announces $100 Million Series B Financing
11/07/2019 / 12:00 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
11/04/2019 / 23:27 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
10/29/2019 / 18:45 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medical Care AG & Co. KGaA - FMS
10/23/2019 / 18:05 - GlobeNewswire - Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®
01/27/2011 / 08:31 - GlobeNewswire
Real-time